(Q36810774)

English

Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension

scientific article published on January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

phase II clinical trial

0 references

arterial hypertension

0 references

idiopathic pulmonary arterial hypertension

0 references

Nicholas W Morrell

object named as

Nicholas W Morrell

13

0 references

Peter A. Robbins

object named as

Peter A Robbins

7

0 references

Joanna Pepke-Zaba

11

object named as

Joanna Pepke-Zaba

1 reference

Europe PubMed Central

16 August 2017

PMC publication ID

15

object named as

Deborah Ashby

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Luke S G E Howard

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Geoffrey M J Watson

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

John Wharton

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Christopher J Rhodes

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kakit Chan

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Rajeshree Khengar

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

David G Kiely

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Robin Condliffe

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Charlie A Elliott

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Karen Sheares

12

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Rachel Davies

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

J Simon R Gibbs

16

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Martin R Wilkins

17

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

1 January 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Pulmonary circulation

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

100-107

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Iron chelation inhibits the development of pulmonary vascular remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Pulmonary hypertension-induced GATA4 activation in the right ventricle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

The increase in pulmonary arterial pressure caused by hypoxia depends on iron status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Iron metabolism in the anemia of chronic disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Anemia of chronic disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

ATS/ACCP Statement on cardiopulmonary exercise testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Inhaled iloprost for severe pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

29 September 2017

Serum transferrin receptor as an index of iron absorption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

27 June 2018

Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Iron deficiency is common in idiopathic pulmonary arterial hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Iron deficiency: an ominous sign in patients with systolic chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Ferric carboxymaltose in patients with heart failure and iron deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641712

5 September 2018

Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/23662181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23662181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4103/2045-8932.109923

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36810774&oldid=1657344607"